Vitamins in Gynecologic Malignancies

Area of Science:

• Oncology
• Nutritional Biochemistry

Background:

• Classical chemotherapeutic treatments are standard for cancer therapy.
• The role of vitamins in cancer prevention and treatment is an area of ongoing research.

Purpose of the Study:

• To investigate the synergistic effects of vitamin derivatives combined with chemotherapy.
• To explore the association between vitamin intake and the risk of specific cancers and infections.

Main Methods:

• Review of studies on drug combinations (e.g., 9cUAB130 with carboplatin, cisplatin with TAC-101, cisplatin with calcitriol).
• Analysis of epidemiological data linking vitamin intake (thiamine, C, beta-carotene, E, B vitamins) to cancer risk and HPV infection.

Main Results:

• Drug combinations demonstrated enhanced cytotoxic effects and reduced ovarian tumor volume.
• Increased vitamin D receptor (VDR) expression was observed with cisplatin, calcitriol, and progesterone.
• Specific vitamin intakes were associated with reduced risks of HPV infection, cervical neoplasia, and endometrial cancer.
• A U-shaped relationship was noted between B vitamins and clinical outcomes.

Conclusions:

• Vitamin derivatives can enhance the efficacy of chemotherapy, particularly in ovarian cancer.
• Adequate and balanced vitamin intake is crucial for cancer prevention and may influence treatment outcomes.
• Individual tumor characteristics and cell lines impact the effectiveness of vitamin-based therapies.